SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-336713
Filing Date
2018-11-28
Accepted
2018-11-28 17:18:03
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d657412ds3.htm S-3 284849
2 EX-4.7 d657412dex47.htm EX-4.7 293211
3 EX-5.1 d657412dex51.htm EX-5.1 17494
4 EX-23.1 d657412dex231.htm EX-23.1 1768
5 GRAPHIC g657412g33q91.jpg GRAPHIC 41162
6 GRAPHIC g657412g40n70.jpg GRAPHIC 3481
  Complete submission text file 0001193125-18-336713.txt   660166
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-228581 | Film No.: 181206412
SIC: 3826 Laboratory Analytical Instruments